JP2008507531A5 - - Google Patents

Download PDF

Info

Publication number
JP2008507531A5
JP2008507531A5 JP2007522672A JP2007522672A JP2008507531A5 JP 2008507531 A5 JP2008507531 A5 JP 2008507531A5 JP 2007522672 A JP2007522672 A JP 2007522672A JP 2007522672 A JP2007522672 A JP 2007522672A JP 2008507531 A5 JP2008507531 A5 JP 2008507531A5
Authority
JP
Japan
Prior art keywords
composition
angptl4
hepatocytes
subject
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007522672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008507531A (ja
JP5318412B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/025650 external-priority patent/WO2006014678A2/en
Publication of JP2008507531A publication Critical patent/JP2008507531A/ja
Publication of JP2008507531A5 publication Critical patent/JP2008507531A5/ja
Application granted granted Critical
Publication of JP5318412B2 publication Critical patent/JP5318412B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007522672A 2004-07-20 2005-07-19 アンジオポエチン様４タンパク質を使用する組成物および方法 Expired - Fee Related JP5318412B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58987504P 2004-07-20 2004-07-20
US60/589,875 2004-07-20
PCT/US2005/025650 WO2006014678A2 (en) 2004-07-20 2005-07-19 Compositions and methods of using angiopoietin-like 4 protein

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011184642A Division JP2011235179A (ja) 2004-07-20 2011-08-26 アンジオポエチン様４タンパク質を使用する組成物および方法

Publications (3)

Publication Number Publication Date
JP2008507531A JP2008507531A (ja) 2008-03-13
JP2008507531A5 true JP2008507531A5 (https=) 2008-08-07
JP5318412B2 JP5318412B2 (ja) 2013-10-16

Family

ID=35787695

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007522672A Expired - Fee Related JP5318412B2 (ja) 2004-07-20 2005-07-19 アンジオポエチン様４タンパク質を使用する組成物および方法
JP2011184642A Withdrawn JP2011235179A (ja) 2004-07-20 2011-08-26 アンジオポエチン様４タンパク質を使用する組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011184642A Withdrawn JP2011235179A (ja) 2004-07-20 2011-08-26 アンジオポエチン様４タンパク質を使用する組成物および方法

Country Status (18)

Country Link
US (3) US7371384B2 (https=)
EP (1) EP1781698B1 (https=)
JP (2) JP5318412B2 (https=)
KR (1) KR20070061524A (https=)
CN (1) CN101080419B (https=)
AU (1) AU2005269758B2 (https=)
BR (1) BRPI0513477A (https=)
CA (1) CA2574791A1 (https=)
DK (1) DK1781698T3 (https=)
HU (1) HUE029170T2 (https=)
IL (4) IL180752A0 (https=)
LT (1) LT1781698T (https=)
MX (1) MX2007000783A (https=)
NO (1) NO342525B1 (https=)
NZ (2) NZ552957A (https=)
RU (2) RU2380411C2 (https=)
WO (1) WO2006014678A2 (https=)
ZA (1) ZA200701184B (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
SI1771474T1 (sl) * 2004-07-20 2010-06-30 Genentech Inc Inhibitorji angiopoetinu podobnega proteina kombinacije in njihova uporaba
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
LT1781698T (lt) * 2004-07-20 2016-09-26 Genentech, Inc. Į angiopoetiną panašaus baltymo 4 kompozicijos ir panaudojimo būdai
WO2006074228A1 (en) * 2005-01-07 2006-07-13 Lexicon Pharmaceuticals, Inc. Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 )
WO2007024723A2 (en) * 2005-08-19 2007-03-01 Washington University In St. Louis Methods and compositions for treating gastrointestinal radiosensitivity in a subject
EP2050335A1 (en) * 2006-02-17 2009-04-22 Genentech, Inc. Gene disruptions, compositions and methods relating thereto
CN101970012A (zh) 2007-09-14 2011-02-09 日东电工株式会社 药物载体
EP2344890B1 (en) * 2008-10-20 2021-08-11 Liposcience, Inc. Lipoprotein insulin resistance indexes and related methods
WO2011046515A1 (en) * 2009-10-14 2011-04-21 Nanyang Technological University Antiproliferative agent
CN102753186B (zh) * 2010-01-08 2016-09-14 Isis制药公司 血管生成素样3表达的调节
US20130023473A1 (en) * 2010-01-20 2013-01-24 Stephane Germain Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity
US9139629B2 (en) 2010-06-05 2015-09-22 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
EP3318269B1 (en) * 2010-06-05 2024-03-13 Chugh, Sumant S. Use of an angiopoietin-like 4 (angptl4) polypeptide in the manufacture of a medicament for the treatment of proteinuria.
US9475850B2 (en) * 2010-06-05 2016-10-25 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
CA2824434A1 (en) * 2011-01-08 2012-07-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102692500B (zh) * 2011-03-21 2015-06-10 上海市肿瘤研究所 Angptl4作为血清学检测肝癌转移的标志物及其应用
CN102692496B (zh) * 2011-03-21 2015-10-28 上海市肿瘤研究所 Angptl4作为缺氧检测的标志物及其应用
CN102242198A (zh) * 2011-05-25 2011-11-16 信阳师范学院 通过angptl4基因多态性进行牛育种方法
EP2723758B1 (en) * 2011-06-21 2018-06-20 Alnylam Pharmaceuticals, Inc. Angiopoietin-like 3 (angptl3) irna compostions and methods of use thereof
CN103635483B (zh) 2011-07-01 2016-11-09 孟山都技术公司 用于选择性调控蛋白质表达的方法和组合物
CN103782177B (zh) * 2011-08-08 2017-10-03 南洋理工大学 血管生成素样4及其在调节细胞渗漏中的用途
CA2857686C (en) * 2011-12-09 2023-01-17 Metabolic Pharmaceuticals Pty Ltd Use of growth hormone fragments
TW201823460A (zh) 2012-05-29 2018-07-01 美商再生元醫藥公司 生產細胞株增強子
CN104822419B (zh) * 2012-07-19 2020-08-18 南洋理工大学 血管生成素样4及其用于伤口愈合的方法
CA2906982C (en) * 2013-03-15 2022-05-31 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
DK2992098T3 (da) 2013-05-01 2019-06-17 Ionis Pharmaceuticals Inc Sammensætninger og fremgangsmåder til modulering af hbv- og ttr-ekspression
EP3021942A4 (en) * 2013-07-19 2017-04-19 The Regents of The University of California Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
PT3087183T (pt) 2013-12-24 2020-10-08 Ionis Pharmaceuticals Inc Modulação da expressão da proteína relacionada com angiopoietina 3
WO2015123576A2 (en) * 2014-02-17 2015-08-20 The Brigham And Women's Hospital, Inc. Targeted nanoparticle compositions and methods of their use to treat obesity
US9382540B2 (en) 2014-05-01 2016-07-05 Isis Pharmaceuticals, Inc Compositions and methods for modulating angiopoietin-like 3 expression
WO2016020882A2 (en) 2014-08-07 2016-02-11 Novartis Ag Angiopoetin-like 4 (angptl4) antibodies and methods of use
WO2016020880A2 (en) 2014-08-07 2016-02-11 Novartis Ag Angiopoietin-like 4 antibodies and methods of use
CN105021827B (zh) * 2015-07-17 2016-09-28 北京大学第一医院 检测血清血管生成素样蛋白2含量的物质在制备检测肝脏炎症和纤维化程度产品中的应用
AU2016296468B2 (en) 2015-07-22 2020-08-27 Monsanto Technology Llc Methods and compositions for selective regulation of protein expression
KR20250078597A (ko) 2015-11-06 2025-06-02 아이오니스 파마수티컬즈, 인코포레이티드 아포리포프로테인 (a) 발현 조정
AU2017286835B2 (en) * 2016-06-29 2023-12-14 Crispr Therapeutics Ag Compositions and methods for gene editing
EP3880819A2 (en) 2018-11-13 2021-09-22 Lipigon Pharmaceuticals AB Angptl4 oligonucleotides influencing the regulation of the fatty acid metabolism
EP4037713A4 (en) * 2019-11-06 2023-11-01 Northwestern University Inhibition of the ve-ptp phosphatase protects the kidney from ischemia-reperfusion injury
CA3164050A1 (en) * 2019-12-09 2021-06-17 Empirico Inc. Oligonucleotides for treatment of angiopoietin like 4 (angptl4) related diseases
CN120254294B (zh) * 2025-06-05 2025-09-09 南昌大学第一附属医院 Angptl3在乙肝相关慢加急性肝衰竭预后中的应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227158A (en) 1991-06-10 1993-07-13 Genentech, Inc. Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6348350B1 (en) 1997-09-19 2002-02-19 Genentech, Inc. Ligand homologues
US20030207375A1 (en) 1997-10-24 2003-11-06 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU1931599A (en) 1997-12-19 1999-07-12 Zymogenetics Inc. Angiopoietin homolog, dna encoding it, and method of making it
IL138216A0 (en) 1998-03-02 2001-10-31 Millennium Pharm Inc Novel fdrg protein and nucleic acid molecules and uses therefor
US20030099994A1 (en) 1998-03-02 2003-05-29 Millennium Pharamceuticals, Inc. Novel FDRG protein and nucleic acid molecules and uses therefor
JP2000026767A (ja) 1998-05-01 2000-01-25 Daikin Ind Ltd 熱硬化性粉体塗料組成物
CA2331154A1 (en) 1998-06-16 1999-12-23 Human Genome Sciences, Inc. Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
AU4643699A (en) 1998-06-24 2000-01-10 Compugen Ltd. Angiopoietin-like growth factor sequences
WO2001054477A2 (en) 2000-01-25 2001-08-02 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001053455A2 (en) 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2000308488A (ja) 1999-02-23 2000-11-07 Herikkusu Kenkyusho:Kk 血管新生に関連するタンパク質および該タンパク質をコードする遺伝子
AU3391200A (en) 1999-03-04 2000-09-21 Corixa Corporation Compositions and methods for breast cancer therapy and diagnosis
PT1626058E (pt) 1999-03-08 2008-02-15 Genentech Inc Composições e métodos para o diagnóstico de tumores
WO2003004623A2 (en) 2001-03-27 2003-01-16 Human Genome Sciences, Inc. Human secreted proteins
AU4200900A (en) 1999-04-09 2000-11-14 Human Genome Sciences, Inc. 49 human secreted proteins
ATE420177T1 (de) 1999-04-16 2009-01-15 Genentech Inc Vaskuläre endothelzellen wachstumsfaktor (vegf) varianten und dessen verwendungen
AU5979300A (en) 1999-07-02 2001-01-22 Bayer Aktiengesellschaft Angiopoietin-6 and uses thereof
EP1210363A2 (en) 1999-07-16 2002-06-05 Hyseq, Inc. Novel angiopoietin materials and methods
EP1196576A2 (en) 1999-07-20 2002-04-17 Curagen Corporation Secreted polypeptides and corresponding polynucleotides
US20030207348A1 (en) 1999-07-20 2003-11-06 Shimkets Richard A. Polypeptides and polynucleotides encoding same
AU2001243142A1 (en) 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
CN1315451A (zh) 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人血管形成素类似因子45和编码这种多肽的多核苷酸
AU2001249929A1 (en) 2000-04-07 2001-10-23 Dana-Farber Cancer Institute Inc. Fdrg proteins and nucleic acid molecules and uses therefor
AU784231B2 (en) * 2000-06-23 2006-02-23 Schering Aktiengesellschaft Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use (II)
US6673545B2 (en) 2000-07-28 2004-01-06 Incyte Corporation Prostate cancer markers
CN1170850C (zh) 2000-09-19 2004-10-13 上海市肿瘤研究所 人血管生成素样蛋白和编码序列及其用途
US20030120056A1 (en) 2000-10-16 2003-06-26 Audrey Goddard TIE ligand homologues
IL159153A0 (en) 2001-06-08 2004-06-01 Sankyo Co Methods for testing drugs for treating or preventing diseases such as hyperlipidemia
WO2003010205A1 (en) 2001-07-26 2003-02-06 Duke University Medical Center Genes induced by hypoxia
AU2002330039A1 (en) 2001-09-17 2003-04-01 Eos Biotechnology, Inc. Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2003040330A2 (en) 2001-11-05 2003-05-15 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20040038230A1 (en) 2001-11-05 2004-02-26 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1451578B1 (en) 2001-11-16 2013-08-21 Genentech, Inc. Use of angptl3 antagonists for the treatment of liver diseases
WO2003048185A2 (en) 2001-11-30 2003-06-12 Genvec, Inc. Angiopioetin related factors
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
IL165392A0 (en) 2002-06-05 2006-01-15 Genentech Inc Compositions and methods for liver growth and liver protection
US20050239706A1 (en) 2003-10-31 2005-10-27 Washington University In St. Louis Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
CA2499791A1 (en) 2004-03-30 2005-09-30 F. Hoffmann-La Roche Ag Angptl4/fiaf as marker for ppardelta modulation
LT1781698T (lt) * 2004-07-20 2016-09-26 Genentech, Inc. Į angiopoetiną panašaus baltymo 4 kompozicijos ir panaudojimo būdai
SI1771474T1 (sl) * 2004-07-20 2010-06-30 Genentech Inc Inhibitorji angiopoetinu podobnega proteina kombinacije in njihova uporaba
WO2006074228A1 (en) * 2005-01-07 2006-07-13 Lexicon Pharmaceuticals, Inc. Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 )

Similar Documents

Publication Publication Date Title
JP2008507531A5 (https=)
RU2007106075A (ru) Композиции и способы применения ангиопоэтинподобного белка 4
JP7756671B2 (ja) 活性比が最適化されたｆｇｆ２１化合物／ｇｌｐ－１ｒアゴニスト組合せ物
Nair et al. Bacterially induced bone destruction: mechanisms and misconceptions
ES2661500T3 (es) Variantes de HMGB1 y sus usos
CN112566655B (zh) 具有优化的活性比率的fgf21化合物/glp-1r激动剂组合
EP1487488A4 (en) SPECIFIC ANTIBODIES AGAINST AMYLOID BETA PEPTIDE, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE THEREOF
JP2008513367A5 (https=)
JP2012505837A5 (https=)
CL2007003472A1 (es) Sal fumarato de (alfa s,beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoxi-alfa-1-naftalenil-beta-fenil-3-quinolinaetanol; proceso de preparacion; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamie
MX353319B (es) Composiciones y metodos relacionados con anticuerpos del receptor de glucagon.
JP2006523682A5 (https=)
JP2006507231A5 (https=)
WO2004074486A3 (en) Fusion proteins of interferon alpha muteins with improved properties
JP2005523681A5 (https=)
RU2001132140A (ru) Рекомбинантный рецептор коллагена на тромбоцитах гликопротеин VI и его применение в фармацевтике
WO2004062555A3 (en) Use of natriuretic peptides for the treatment of stature disorders related to the shox gene
JP2010507666A5 (https=)
JP2025169473A (ja) 低減された活性を有するｇｌｐ－１ｒアゴニストペプチド
EP2083018A3 (en) Compositions and methods relating to STOP-1
DE1206274T1 (de) Verwendung von interleukin-18-inhibitoren zur hemmung von tumormetastasierung
JP5036546B2 (ja) 胸腺特異的タンパク質
DK1969003T3 (da) Anvendelser af et neurotrofisk faktor-protein
JP7687637B2 (ja) 抗ウイルス活性を有するペプチド、当該ペプチドを含む抗ウイルス剤、当該抗ウイルス剤の製造方法
CL2007003216A1 (es) Sal de 2(s), 4(s), 5(s), 7(s)-n-(3-amino-2,2-dimetil-3-oxo-propil)2,7-di(1-metil-etil)-4-hidroxi-5-amino-8-[4-metoxi-3-(3-metoxi-propoxi)fenil]-octanamida; proceso de preparacion; composicion farmaceutica; y uso para la profilaxis o tratamiento de en